z-logo
open-access-imgOpen Access
Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19
Author(s) -
Sterling Edmonds,
Andrea MacGregor,
Agnieszka Doll,
İpek Eren Vural,
Janice Graham,
Katherine Fierlbeck,
Joel Lexchin,
Peter Doshi,
Matthew Herder
Publication year - 2020
Publication title -
journal of law and the biosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 18
ISSN - 2053-9711
DOI - 10.1093/jlb/lsaa083
Subject(s) - scrutiny , transparency (behavior) , covid-19 , open data , face (sociological concept) , public relations , business , internet privacy , political science , medicine , infectious disease (medical specialty) , computer science , virology , sociology , disease , law , social science , pathology , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom